Evidence map›Paper›PMID 41400088›Full record

ArticleThe Analyst2026

Advanced multimodal imaging: FLIM, PLIM, and FluoRaman enabled by novel diarylacetylene probes.

Joshua G Hughes, Dimitrios Tsikritsis, Alexandra E Bailie, Camilla Dondi, Eva Dias, Helen H Fielding, Natalie A Belsey, Michael Shaw, Stanley W Botchway, Carrie A Ambler and 2 more

Abstract read
In one paragraph

Article in The Analyst, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Joshua G HughesDepartment of Chemistry, University College London, 20 Gordon Street, London WC1H 0AJ, UK.ORCID http://orcid.org/0000-0002-4312-9002
Dimitrios TsikritsisChemical and Biological Sciences Department, National Physical Laboratory, Hampton Road, Teddington, Middlesex, TW11 0LW, UK.
Alexandra E BailieCentral Laser Facility, STFC Rutherford Appleton Laboratory, Didcot, Oxfordshire OX11 0QX, UK.ORCID http://orcid.org/0000-0001-5641-6003
Camilla DondiChemical and Biological Sciences Department, National Physical Laboratory, Hampton Road, Teddington, Middlesex, TW11 0LW, UK.
Eva DiasLightOx Ltd, 65 Westgate Road, Newcastle upon Tyne NE1 1SG, UK. david.chisholm@lightox.co.uk.
Helen H FieldingDepartment of Chemistry, University College London, 20 Gordon Street, London WC1H 0AJ, UK.ORCID http://orcid.org/0000-0003-1572-0070
Natalie A BelseyChemical and Biological Sciences Department, National Physical Laboratory, Hampton Road, Teddington, Middlesex, TW11 0LW, UK.ORCID http://orcid.org/0000-0001-7773-0966
Michael ShawChemical and Biological Sciences Department, National Physical Laboratory, Hampton Road, Teddington, Middlesex, TW11 0LW, UK.ORCID http://orcid.org/0000-0001-6099-3217
Stanley W BotchwayCentral Laser Facility, STFC Rutherford Appleton Laboratory, Didcot, Oxfordshire OX11 0QX, UK.
Carrie A AmblerLightOx Ltd, 65 Westgate Road, Newcastle upon Tyne NE1 1SG, UK. david.chisholm@lightox.co.uk.
John M GirkinCentre for Advanced Instrumentation, Department of Physics, University of Durham, Lower Mountjoy, South Road, Durham DH1 3LS, UK.
David R ChisholmLightOx Ltd, 65 Westgate Road, Newcastle upon Tyne NE1 1SG, UK. david.chisholm@lightox.co.uk.ORCID http://orcid.org/0000-0003-3478-8767

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In drug design, understanding the subcellular localisation and physicochemical behaviour of candidate molecules is essential for optimising their efficacy and elucidating their mechanisms of action. Imaging probes are routinely employed for this purpose, though most studies rely on a single imaging modality. By integrating multiple imaging techniques into a multimodal system, a more comprehensive understanding of localisation, microenvironment, and physicochemical interactions can be achieved. Yet, there remains a scarcity of specialised imaging probes with well-defined photophysical profiles, especially those that combine luminescence with a Raman-active tag in the cell-silent region, where signal clarity is maximised. Such probes could function independently or be conjugated to drugs or targeting moieties as dual-mode imaging tags. In this study, we showcase the application of a suite of advanced imaging modalities: fluorescence microscopy (CLSM); Fluorescence Lifetime Imaging Microscopy (FLIM); Phosphorescence Lifetime Imaging Microscopy (PLIM); and simultaneous fluorescence and Raman spectroscopy (FluoRaman). The modalities were exemplified by a series of novel, highly solvatochromic diarylacetylene-based photosensitisers that feature alkyne Raman tags and exhibit diverse subcellular localisation.

Indexed as

AlkynesFluorescent DyesMultimodal ImagingOptical ImagingPhotosensitizing AgentsHeLa CellsHumansMicroscopy, FluorescenceSpectrum Analysis, RamanAlkynesFluorescent DyesPhotosensitizing Agents

Identifiers

PMID41400088
PMCPMC12706839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.